Proteomics of chronic pressure ulcers

Wound Repair and Regeneration

Volumn 20, Issue 3, 2012, Pages 378-401

  Edsberg, Laura E ^a   Wyffels, Jennifer T ^a   Brogan, Michael S ^a   Fries, Kristin M ^a  

^a DAEMEN COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA1 ANTITRYPSIN PRECURSOR; BIOLOGICAL MARKER; CXCL9 CHEMOKINE; HEMOGLOBIN A; HEMOGLOBIN BETA CHAIN; IMMUNOGLOBULIN GAMMA 1 CHAIN C; IMMUNOGLOBULIN LAMBDA 1 CHAIN C; IMMUNOGLOBULIN LAMBDA CHAIN; ISOENZYME; KERATIN TYPE I; KERATIN TYPE I CYTOSKELETAL 14; KERATIN TYPE II; KERATIN TYPE II CYTOSKELETAL 6A; PROFILIN; PROFILIN I; PSORIASIN; PYRUVATE KINASE; PYRUVATE KINASE M1; PYRUVATE KINASE M2; UNCLASSIFIED DRUG;

AGED; ANTIBODY SCREENING; ARTICLE; CHRONIC WOUND; DECUBITUS; FEMALE; HUMAN; ISOBARIC TAG FOR RELATIVE AND ABSOLUTE QUANTITATION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; MEDICAL DEVICE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; ULCER HEALING; UNINDEXED SEQUENCE; WOUND CLOSURE; WOUND FLUID; WOUND HEALING; CHRONIC DISEASE; EXUDATE; METABOLISM; METHODOLOGY; PATHOLOGY; PREDICTIVE VALUE; PROTEIN MICROARRAY;

AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; PREDICTIVE VALUE OF TESTS; PRESSURE ULCER; PROFILINS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; WOUND HEALING;

EID: 84860630016     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2012.00791.x     Document Type: Article

References (41)

1. National Pressure Ulcer Advisory Panel, European Pressure Ulcer Advisory Panel. Prevention and treatment of pressure ulcers: clinical practice guideline. Washington, DC: National Pressure Ulcer Advisory Panel, 2009.
2. Jaynes CD, Fries K, Brogan M, Karch JE, Baird K, Edsberg LE,. Development of a protocol for biochemical analysis of wound fluids. Acute Care Perspect 2003; 12: 11-15.
3. Wyffels JT, Fries KM, Randall JS, Ha DS, Lodwig CA, Brogan MS, Shero M, Edsberg LE,. Analysis of pressure ulcer wound fluid using two-dimensional electrophoresis. Int Wound J 2010; 7: 236-248.
4. Gygi SP, Aebersold R,. Mass spectrometry and proteomics. Curr Opin Chem Biol 2000; 4: 489-494.
5. Streckfus CF, Mayorga-Wark O, Arreola D, Edwards C, Bigler L, Dubinsky WP,. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest 2008; 26: 159-167. (Pubitemid 351225470)
6. Braun MC, Li L, Ke B, Dubinsky WP, Pickering MC, Chang JY,. Proteomic profiling of urinary protein excretion in the factor H-deficient mouse. Am J Nephrol 2006; 26: 127-135. (Pubitemid 43882396)
7. Hergenroeder G, Redell JB, Moore AN, Dubinsky WP, Funk RT, Crommett J, Clifton GL, Levine R, Valadka A, Dash PK,. Identification of serum biomarkers in brain-injured adults: potential for predicting elevated intracranial pressure. J Neurotrauma 2008; 25: 79-93. (Pubitemid 351252579)
8. Wyffels JT, Edsberg LE,. Granulation tissue of chronic pressure ulcers as predictive indicator of wound closure. Adv Skin Wound Care 2011; 24: 464-473.
9. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G,. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-29. (Pubitemid 30257031)
10. Bhatia VN, Perlman DH, Costello CE, McComb ME,. Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal Chem 2009; 81: 9819-9823.
11. van Rijswijk L,. Full-thickness pressure ulcers: patient and wound healing characteristics. Decubitus 1993; 6: 16-21.
12. Iizaka S, Sanada H, Minematsu T, Oba M, Nakagami G, Koyanagi H, Nagase T, Konya C, Sugama J,. Do nutritional markers in wound fluid reflect pressure ulcer status? Wound Rep Reg 2010; 18: 31-37.
13. Iizaka S, Sanada H, Nakagami G, Sekine R, Koyanagi H, Konya C, Sugama J,. Estimation of protein loss from wound fluid in older patients with severe pressure ulcers. Nutrition 2010; 26: 890-895.
14. Moseley R, Hilton JR, Waddington RJ, Harding KG, Stephens P, Thomas DW,. Comparison of oxidative stress biomarker profiles between acute and chronic wound environments. Wound Rep Reg 2004; 12: 419-429. (Pubitemid 39007042)
15. James TJ, Hughes MA, Cherry GW, Taylor RP,. Simple biochemical markers to assess chronic wounds. Wound Rep Reg 2000; 8: 264-269.
16. Trengove NJ, Langton SR, Stacey MC,. Biochemical analysis of wound fluid from nonhealing and healing chronic leg ulcers. Wound Rep Reg 1996; 4: 234-239. (Pubitemid 126674092)
17. Dealey C, Cameron J, Arrowsmith M,. A study comparing two objective methods of quantifying the production of wound exudate. J Wound Care 2006; 15: 149-153.
18. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK,. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996; 107: 743-748. (Pubitemid 26371092)
19. Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS,. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Rep Reg 2002; 10: 26-37. (Pubitemid 34496479)
20. Heizmann CW, Ackermann GE, Galichet A,. Pathologies involving the S100 proteins and RAGE. Subcell Biochem 2007; 45: 93-138.
21. Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D, Lee K,. S100 proteins in the epidermis. J Invest Dermatol 2004; 123: 23-33. (Pubitemid 38833459)
22. Ruse M, Lambert A, Robinson N, Ryan D, Shon KJ, Eckert RL,. S100A7, S100A10, and S100A11 are transglutaminase substrates. Biochemistry 2001; 40: 3167-3173. (Pubitemid 32205361)
23. Hsu K, Champaiboon C, Guenther BD, Sorenson BS, Khammanivong A, Ross KF, Geczy CL, Herzberg MC,. Anti-infective protective properties of S100 calgranulins. Antiinflamm Antiallergy Agents Med Chem 2009; 8: 290-305.
24. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA,. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003; 170: 3233-3242. (Pubitemid 36302201)
25. Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS,. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol 2007; 42: 1321-1331. (Pubitemid 47537067)
26. Stříž I, Trebichavský I,. Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res 2004; 53: 245-253. (Pubitemid 38797280)
27. Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, Fitzgerald O, Roth J,. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 2003; 42: 1383-1389. (Pubitemid 37407031)
28. Thorey IS, Roth J, Regenbogen J, Halle JP, Bittner M, Vogl T, Kaesler S, Bugnon P, Reitmaier B, Durka S, Graf A, Wockner M, Rieger N, Konstantinow A, Wolf E, Goppelt A, Werner S,. The Ca2+-binding proteins S100A8 and S100A9 are encoded by novel injury-regulated genes. J Biol Chem 2001; 276: 35818-35825.
29. Eming SA, Koch M, Krieger A, Brachvogel B, Kreft S, Bruckner-Tuderman L, Krieg T, Shannon JD, Fox JW,. Differential proteomic analysis distinguishes tissue repair biomarker signatures in wound exudates obtained from normal healing and chronic wounds. J Proteome Res 2010; 9: 4758-4766.
30. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM,. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97: 889-901. (Pubitemid 29375048)
31. Foell D, Seeliger S, Vogl T, Koch HG, Maschek H, Harms E, Sorg C, Roth J,. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax 2003; 58: 613-617. (Pubitemid 36808133)
32. Ye F, Foell D, Hirono KI, Vogl T, Rui C, Yu X, Watanabe S, Watanabe K, Uese K, Hashimoto I, Roth J, Ichida F, Miyawaki T,. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am J Cardiol 2004; 94: 840-844. (Pubitemid 39221519)
33. Gillitzer R, Goebeler M,. Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69: 513-521. (Pubitemid 32294835)
34. Engelhardt E, Toksoy A, Goebeler M, Debus S, Brocker EB, Gillitzer R,. Chemokines IL-8, GROα, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol 1998; 153: 1849-1860. (Pubitemid 28550672)
35. Birgersdotter A, Baumforth KR, Porwit A, Sjoberg J, Wei W, Bjorkholm M, Murray PG, Ernberg I,. Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma. Br J Cancer 2009; 101: 1393-1401.
36. Goebeler M, Yoshimura T, Toksoy A, Ritter U, Brocker EB, Gillitzer R,. The chemokine repertoire of human dermal microvascular endothelial cells and its regulation by inflammatory cytokines. J Invest Dermatol 1997; 108: 445-451. (Pubitemid 27148279)
37. Romagnani P, Lasagni L, Annunziato F, Serio M, Romagnani S,. CXC chemokines: the regulatory link between inflammation and angiogenesis. Trends Immunol 2004; 25: 201-209. (Pubitemid 38372168)
38. Struyf S, Burdick MD, Peeters E, Van den Broeck K, Dillen C, Proost P, Van Damme J, Strieter RM,. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis. Cancer Res 2007; 67: 5940-5948. (Pubitemid 46985030)
39. Takamiya M, Fujita S, Saigusa K, Aoki Y,. Simultaneous detections of 27 cytokines during cerebral wound healing by multiplexed bead-based immunoassay for wound age estimation. J Neurotrauma 2007; 24: 1833-1844.
40. Yates CC, Whaley D, Y-Chen A, Kulesekaran P, Hebda PA, Wells A,. ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. Am J Pathol 2008; 173: 643-652.
41. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM,. Dynamic reciprocity in the wound microenvironment. Wound Rep Reg 2011; 19: 134-148.